Is clinicalintelpulse.theaslangroupllc.com trustworthy?
Reputation, price and real payments, measured by Burs-IA · updated 2026-11-15
- Listado en catálogo, sin medir por Burs-IA
- Uso declarado en x402: 19 llamadas/30 d (no verificado)
| Listings in the Burs-IA map | 15 |
| Platforms | x402 |
| Where it is listed | x402-bazar |
| Category | Calle de la Salud |
| Typical price (declared) | US$0.1 · Base |
| Calls in the last 30 days (declared by the catalog, not verified) | 19 |
| Most unique payers on one listing, 30 days (declared, not verified) | 3 |
| USDC received on Base since 2026-11-15 (measured by Burs-IA on-chain) | US$0.02 |
| Payments counted on-chain | 1 |
| Distinct payers on-chain | 1 |
The catalog declares 19 calls in 30 days. On the Base blockchain, Burs-IA counted 1 USDC payments from 1 distinct payers to its payout wallet since 2026-11-15. On-chain counts start on the date shown and include any USDC transfer to that wallet.
What it offers
- clinicalintelpulse.theaslangroupllc.com/api/… · US$0.02 · Base
ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, en - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.15 · Base
Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gap - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.2 · Base
Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.35 · Base
Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worl - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.15 · Base
Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ tria - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.1 · Base
Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recalls, explains the recall class (I/II/III) - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.2 · Base
Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success - clinicalintelpulse.theaslangroupllc.com/api/… · US$0.1 · Base
Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, ac
How Burs-IA measures this
Reputation combines whether the service answers when we check it, how well it presents itself to agents, honesty of what it declares, and payment safety signals. Declared traffic comes from public catalogs such as the Coinbase x402 Bazaar and is not verified. On-chain figures are read by Burs-IA directly from the Base blockchain (USDC transfers to the seller's payout wallet); payer identities are stored only as anonymous fingerprints.
For agents: /verdad/clinicalintelpulse.theaslangroupllc.com.json · /reputacion?host=clinicalintelpulse.theaslangroupllc.com
En español
clinicalintelpulse.theaslangroupllc.com tiene una reputación Burs-IA de 58/100. Desde el 2026-11-15, Burs-IA contó en la cadena de Base 1 pagos de 1 pagadores distintos (US$0.02). El catálogo declara 19 llamadas en 30 días (no verificado).